Favourites   Have ideas?  Sign in / Register

Positive:   Country: Ireland ↓45.05   Radiotherapy ↓32.31   Disease: Gastrointestinal ↓31.83 «See more»   Disease: Eye  ↑3.19   Biology ↑4.73   Cancer fight ↑17.33

Negative:   Bad infrastructure  ↓2.09   Tobacco ↑1.43


Pharmaceutical segment

ACHV Achieve Life Sciences, Inc. - Common Shares 1.43% up -8.16% 9.59 + Pharmaceutical , Disease: Addictions
- Tobacco
+ My List
ACRX AcelRx Pharmaceuticals, Inc. - Common Stock 0 + Pharmaceutical , Medicine


Last highlighted: Form 8-K: Results of Operations and Financial Condition On January 14, 2021, AcelRx Pharmaceuticals issued a press re.. $ACRX https://t.co/85kZEX2ul8
+ My List
ADMS Adamas Pharmaceuticals, Inc. - Common Stock 0.00% 0 + Medicine, Disease: Neurology/Alzheimer/Parkinson's, Pharmaceutical

+ My List
ADXN Addex Therapeutics Ltd - American Depositary Shares -1.69% up -12.53% 10.84 + Medicine, Disease: Neurology/Alzheimer/Parkinson's, Pharmaceutical

+ My List
AERI Aerie Pharmaceuticals, Inc. - Common Stock 8.46% 8.46% 0 + Disease: Eye , Medicine, Pharmaceutical


Last highlighted: Alert [Press/News Current Report] / Form 8-K filed with the SEC $AERI AERIE PHARMACEUTICALS INC https://t.co/jhemDQoMVR
+ My List
AIKI AIkido Pharma Inc. - Common Stock 0 + Cancer fight, Pharmaceutical , Medicine


Last highlighted: #AIKI SEC report: AIkido Pharma Inc. Current report, item 8.01
SEC Filing Form 8-K filed by AIkido Pharma Inc. -- SEC File Number 211098058
+ My List
AKER Akers Biosciences Inc. - Common Stock 0.00% 0 + Medicine, Pharmaceutical , Immunology, Cancer fight

+ My List
ANIP ANI Pharmaceuticals, Inc. - Common Stock 8.08% 8.08% 0 + Generic, Pharmaceutical , Medicine

+ My List
AQST Aquestive Therapeutics, Inc. - Common Stock -6.92% up -7.44% 0.52 + Medicine, Pharmaceutical

+ My List
ARDS Aridis Pharmaceuticals Inc. - Common Stock -15.83% -15.83% 0 + Disease: Infectious, Pharmaceutical , Medicine

+ My List
ASLN ASLAN Pharmaceuticals Limited - American Depositary Shares 0 + Country: Singapore, Pharmaceutical , Biopharma, Immunology, Medicine


Last highlighted: $ASLN / ASLAN Pharmaceuticals files form 6-K https://t.co/rm8jqdBSsq
+ My List
AUPH Aurinia Pharmaceuticals Inc - Common Shares -0.36% down 10.39% -10.75 + Pharmaceutical , Immunology, Country: Canada


Last highlighted: FORM 10-Q [Quarterly Report] recently SEC filed. $AUPH #AuriniaPharmaceuticals Inc. Aurinia Pharmaceuticals Inc https://t.co/ei2FxR7sZR
+ My List
AVCO Avalon GloboCare Corp. - Common Stock 0 + Cancer fight, Medicine, Immunology, Pharmaceutical


Last highlighted: #AVCO SEC report: Avalon GloboCare Corp. Current report, items 1.01 and 9.01
SEC Filing Form 8-K filed by Avalon GloboCare Corp. -- SEC File Number 211089336
+ My List
BIMI BOQI International Medical Inc. - Common Stock -7% up -10% 3 + Country: China, Medicine, Pharmaceutical

+ My List
CMPI Checkmate Pharmaceuticals, Inc. - Common Stock 327.57% up 326.75% 0.81999999999999 + Cancer fight, Medicine, Pharmaceutical


Last highlighted: #CMPI SEC report: Checkmate Pharmaceuticals, Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Checkmate Pharmaceuticals, Inc. -- SEC File Number 211142205
+ My List
CNST Constellation Pharmaceuticals, Inc. - Common Stock 0.00% 0 + Cancer fight, Medicine, Pharmaceutical

+ My List
CPRX Catalyst Pharmaceuticals, Inc. - Common Stock 4.65% up -7.5% 12.15 + Pharmaceutical , Medicine


Last highlighted: #CPRX SEC report: CATALYST PHARMACEUTICALS, INC. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by CATALYST PHARMACEUTICALS, INC. -- SEC File Number
+ My List
CRNX Crinetics Pharmaceuticals, Inc. - Common Stock 2.65% down 7.93% -5.28 + Pharmaceutical , Disease: Endocrine disease, Medicine


Last highlighted: #CRNX SEC report: Crinetics Pharmaceuticals, Inc. Automatic shelf registration statement of securities of well-known seasoned issuers
SEC Filing Form S-3ASR filed by Crinetics Pharmaceuticals, Inc. -- SEC File Number 211161145
+ My List
CRVS Corvus Pharmaceuticals, Inc. - Common Stock up -7.14% 7.14 + Medicine, Immunology, Pharmaceutical

+ My List
CTXR Citius Pharmaceuticals, Inc. - Common Stock up -12.75% 12.75 + Pharmaceutical , Medicine


Last highlighted: #CTXR SEC report: Citius Pharmaceuticals, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Citius Pharmaceuticals, Inc. -- SEC File Number 211081579
+ My List
CTXRW Citius Pharmaceuticals, Inc. - Warrant 0 + Pharmaceutical , Medicine

+ My List
CYCC Cyclacel Pharmaceuticals, Inc. - Common Stock 2.21% down 7.75% -5.54 + Biotechnology, Biopharma, Pharmaceutical , Medicine, Gene and cell
- Bad infrastructure
+ My List
DRNA Dicerna Pharmaceuticals, Inc. - Common Stock 0.00% 0 + Biopharma, Pharmaceutical , RNA, Medicine


Last highlighted: $DRNA 📜 Dicerna Pharmaceuticals, Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits https://t.co/pVex4DfvFC 30s delayed.
+ My List
DYAI Dyadic International, Inc. - Common Stock -7.39% -7.39% 0 + Medicine, Biopharma, Pharmaceutical

+ My List
ENDP Endo International plc - Ordinary Shares -45.05% -45.05% 0 + Medicine, Pharmaceutical , Country: Ireland, Generic


Last highlighted: Tracking Larry Robbins' Glenview Capital Management Portfolio - Q4 2020 Update
+ My List
ENTX Entera Bio Ltd. - Ordinary Shares 6.31% 6.31% 0 + Country: Israel, Biotechnology, Pharmaceutical


Last highlighted: $ENTX 📜 SEC Form 6-K filed by Entera Bio Ltd. https://t.co/dws8IKVGAV #healthcare
+ My List
ENTXW Entera Bio Ltd. - Warrant 0 + Country: Israel, Biotechnology, Pharmaceutical

+ My List
EPIX ESSA Pharma Inc. - Common Stock 4.45% down 8.01% -3.56 + Pharmaceutical , Country: Canada, Cancer fight


Last highlighted: #EPIX SEC report: ESSA Pharma Inc. [Amend] Statement of acquisition of beneficial ownership by individuals
SEC Filing Form SC 13G/A filed by ESSA Pharma Inc. -- SEC File Number 211182253
+ My List
ETON Eton Pharmaceuticals, Inc. - Common Stock -1.69% up -7.32% 5.63 + Medicine, Pharmaceutical

+ My List
EVOK Evoke Pharma, Inc. - Common Stock -55.4% -55.4% 0 + Pharmaceutical , Medicine, Disease: Gastrointestinal


Last highlighted: FORM 8-K [Press/News Current Report] recently SEC filed. $EVOK Evoke Pharma Inc https://t.co/fwtsPe3b5z
+ My List
EYPT EyePoint Pharmaceuticals, Inc. - Common Stock 5.17% up -9.76% 14.93 + Pharmaceutical , Disease: Eye , Medicine, Biopharma


Last highlighted: #EYPT SEC report: EyePoint Pharmaceuticals, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by EyePoint Pharmaceuticals, Inc. -- SEC File Number 211142305
+ My List
FBIO Fortress Biotech, Inc. - Common Stock -6.73% up -8.65% 1.92 + Pharmaceutical , Biopharma, Biotechnology, Medicine

+ My List
FUSN Fusion Pharmaceuticals Inc. - Common Shares -32.31% -32.31% 0 + Pharmaceutical , Country: Canada, Medicine, Radiotherapy, Cancer fight

+ My List
HRTX Heron Therapeutics, Inc. - Common Stock -3.23% up -18.63% 15.4 + Medicine, Pharmaceutical

+ My List
HUGE FSD Pharma Inc. - Class B Subordinate Voting Shares -8.91% down -4.95% -3.96 + Pharmaceutical , Medicine

+ My List
ICPT Intercept Pharmaceuticals, Inc. - Common Stock 0.48% up -9.64% 10.12 + Pharmaceutical , Medicine, Biopharma, Disease: Liver


Last highlighted: #ICPT SEC report: INTERCEPT PHARMACEUTICALS, INC. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by INTERCEPT PHARMACEUTICALS, INC. -- SEC File Number
+ My List
ITRM Iterum Therapeutics plc - Ordinary Share 0 + Pharmaceutical , Medicine, Disease: Infectious

+ My List
KALV KalVista Pharmaceuticals, Inc. - Common Stock -1.25% up -13.4% 12.15 + Pharmaceutical , Medicine


Last highlighted: #KALV SEC report: KalVista Pharmaceuticals, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]
SEC Filing Form 10-K filed by KalVista Pharmaceuticals, Inc. -- SEC File Number 211087997
+ My List
KMDA Kamada Ltd. - Ordinary Shares -3.52% -3.52% 0 + Biopharma, Pharmaceutical , Medicine


Last highlighted: #KMDA SEC report: KAMADA LTD Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by KAMADA LTD -- SEC File Number 211161938
+ My List
KNSA Kiniksa Pharmaceuticals, Ltd. - Class A Common Stock -0.37% up -7.06% 6.69 + Pharmaceutical , Biopharma, Medicine


Last highlighted: #KNSA SEC report: Kiniksa Pharmaceuticals, Ltd. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Kiniksa Pharmaceuticals, Ltd. -- SEC File Number 211138062
+ My List
KPTI Karyopharm Therapeutics Inc. - Common Stock up -10.02% 10.02 + Cancer fight, Disease: Oncology, Pharmaceutical , Medicine


Last highlighted: #KPTI SEC report: Karyopharm Therapeutics Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Karyopharm Therapeutics Inc. -- SEC File Number
+ My List
MACK Merrimack Pharmaceuticals, Inc. - Common Stock -2.24% down 7.72% -9.96 + Pharmaceutical , Cancer fight, Medicine

+ My List
MBRX Moleculin Biotech, Inc. - Common Stock -7.58% -7.58% 0 + Biotechnology, Pharmaceutical , Medicine, Cancer fight, Disease: Infectious


Last highlighted: #MBRX SEC report: Moleculin Biotech, Inc. Statement of changes in beneficial ownership of securities
+ My List
MTP Midatech Pharma PLC - American Depositary Shares 0 + Country: Greate Britain, Medicine, 3D, Pharmaceutical


Last highlighted: $MTP 📜 SEC Form 6-K filed by Midatech Pharma PLC https://t.co/bXrzkJUXsF #majorpharmaceuticals #healthcare
+ My List
NEOS Neos Therapeutics, Inc. - Common Stock 0.00% 0 + Medicine, Pharmaceutical , Disease: Neurology/Alzheimer/Parkinson's

+ My List
OCUP Ocuphire Pharma, Inc. - Common Stock -4.07% -4.07% 0 + Disease: Eye , Biopharma, Medicine, Pharmaceutical


Last highlighted: $OCUP 📜 Ocuphire Pharma, Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits https://t.co/xMAN0ucl8b 15s delayed.
+ My List
OPNT Opiant Pharmaceuticals, Inc. - Common Stock 0.54% down 20.62% -20.08 + Pharmaceutical , Medicine, Alcohol, Cannabis


Last highlighted: #OPNT SEC report: OPIANT PHARMACEUTICALS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by OPIANT PHARMACEUTICALS, INC. -- SEC File Number 211148259
+ My List
OPTN OptiNose, Inc. - Common Stock 1.99% down 9.73% -7.74 + Medicine, Disease: Ear/Nose, Pharmaceutical

+ My List
ORIC Oric Pharmaceuticals, Inc. - Common Stock -7.43% -7.43% 0 + Pharmaceutical , Medicine, Disease: Oncology, Cancer fight


Last highlighted: #ORIC SEC report: Oric Pharmaceuticals, Inc. Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by Oric Pharmaceuticals, Inc. -- SEC File Number 211078899
+ My List
ORMP Oramed Pharmaceuticals Inc. - Common Stock -11% -11% 0 + Medicine, Pharmaceutical

+ My List
OSMT Osmotica Pharmaceuticals plc - Ordinary Shares 0.00% 0 + Pharmaceutical , Women Health, Biopharma

+ My List
PLXP PLx Pharma Inc. - Common Stock -8.25% -8.25% 0 + Disease: Gastrointestinal, Medicine, Pharmaceutical

+ My List
PMVP PMV Pharmaceuticals, Inc. - Common Stock 0.37% down 8.23% -7.86 + Medicine, Cancer fight, Pharmaceutical


Last highlighted: #PMVP SEC report: PMV Pharmaceuticals, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by PMV Pharmaceuticals, Inc. -- SEC File Number
+ My List
PRTK Paratek Pharmaceuticals, Inc. - Common Stock 5.26% down 8.33% -3.07 + Pharmaceutical , Biopharma, Medicine, Life Sciences

+ My List
RETA Reata Pharmaceuticals, Inc. - Class A Common Stock 2.33% down 7.74% -5.41 + Pharmaceutical , Disease: Kidney, Medicine

+ My List
RSSS Research Solutions, Inc - Common Stock -0.95% down 8.65% -9.6 + Life Sciences, SaaS, Pharmaceutical

+ My List
RYTM Rhythm Pharmaceuticals, Inc. - Common Stock -0.86% up -8.49% 7.63 + Pharmaceutical , Gene and cell, Medicine


Last highlighted: #RYTM SEC report: RHYTHM PHARMACEUTICALS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by RHYTHM PHARMACEUTICALS, INC. -- SEC File Number 211137945
+ My List
SCPH scPharmaceuticals Inc. - Common Stock -2.63% up -10.87% 8.24 + Pharmaceutical , Medicine


Last highlighted: $SCPH [15s. delayed] filed form 8-K on July 01, 08:10:00: Item8.01: Other Material Events https://t.co/XvnQaKOhSx
+ My List
SLRX Salarius Pharmaceuticals, Inc. - Common Stock 0 + Cancer fight, Biotechnology, Medicine, Pharmaceutical


Last highlighted: $SLRX 8-K Salarius Pharmaceuticals (8 Mar, 4:30pm) 📰 Salarius Announces Pricing of $20 Million Underwritten Public Offering of Common Stock https://t.co/AWdEx2wgvD #SLRX #8K #SalariusPharmaceuticals #News
+ My List
TCON TRACON Pharmaceuticals, Inc. - Common Stock -1.54% down 13.53% -15.07 + Pharmaceutical , Cancer fight, Medicine, Biopharma, Disease: Oncology

+ My List
TENX Tenax Therapeutics, Inc. - Common Stock 0 + Pharmaceutical , Medicine


Last highlighted: #TENX SEC report: TENAX THERAPEUTICS, INC. [Amend] General statement of acquisition of beneficial ownership
SEC Filing Form SC 13D/A filed by TENAX THERAPEUTICS, INC. -- SEC File Number 211083528
+ My List
TXMD TherapeuticsMD, Inc. - Common Stock -6.39% up -11.78% 5.39 + Women Health, Pharmaceutical , Medicine
- Bad infrastructure

Last highlighted: #TXMD SEC report: TherapeuticsMD, Inc. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by TherapeuticsMD, Inc. -- SEC File Number 211142293
+ My List
VSPRU Vesper Healthcare Acquisition Corp. - Unit 0.00% 0 + Acquisitions/Investing, Healthcare, Medicine, Pharmaceutical


Last highlighted: $VSPRU [15s. delayed] filed form 8-K/A on April 27, 08:49:59: Item8.01: Other Material Events https://t.co/lO6rnv4ril
+ My List
XFOR X4 Pharmaceuticals, Inc. - Common Stock -8.73% -8.73% 0 + Cancer fight, Medicine, Pharmaceutical


Last highlighted: #XFOR SEC report: X4 Pharmaceuticals, Inc Current report, item 2.02
SEC Filing Form 8-K filed by X4 Pharmaceuticals, Inc -- SEC File Number 211138073
+ My List
ZNTL Zentalis Pharmaceuticals, Inc. - common stock 4.73% down 18.04% -13.31 + Cancer fight, Biology, Pharmaceutical , Medicine


Last highlighted: #ZNTL SEC report: Zentalis Pharmaceuticals, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Zentalis Pharmaceuticals, Inc. -- SEC File Number
+ My List
ZYNE Zynerba Pharmaceuticals, Inc. - Common Stock -8% -8% 0 + Cannabis, Medicine, Pharmaceutical , Disease: Neuropsychiatric


Last highlighted: #ZYNE SEC report: Zynerba Pharmaceuticals, Inc. Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by Zynerba Pharmaceuticals, Inc. -- SEC File Number 211089272
+ My List
CLVR Clever Leaves Holdings Inc. - Common Shares -2.31% down 18.46% -20.77 + Medicine, Healthcare, Cannabis, Pharmaceutical

+ My List
CLVRW Clever Leaves Holdings Inc. - Warrant 0 + Medicine, Cannabis, Pharmaceutical , Healthcare

+ My List
INM InMed Pharmaceuticals Inc. - Common Shares up -15.84% 15.84 + Country: Canada, Pharmaceutical , Medicine, Cannabinoid-based

+ My List
KMPH KemPharm, Inc. - Common Stock -7.16% -7.16% 0 + Medicine, Pharmaceutical


Last highlighted: #KMPH SEC report: KEMPHARM, INC Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by KEMPHARM, INC -- SEC File Number 211102850
+ My List
PHVS Pharvaris N.V. - Ordinary Shares -2.65% -2.65% 0 + Medicine, Pharmaceutical


Last highlighted: $PHVS 📜 SEC Form 6-K filed by Pharvaris N.V. https://t.co/Ra28QDTJZ3 15s delayed.
+ My List
TERN Terns Pharmaceuticals, Inc. - Common Stock 5.23% 5.23% 0 + Biopharma, Pharmaceutical , Disease: Liver


Last highlighted: $TERN 8-K Terns Pharmaceuticals (14 Jun, 4:40pm) 📰 Terns Reports Positive Top-line Results from Phase 2a LIFT Study of FXR Agonist TERN-101 in Patients with NASH https://t.co/wJNwFxLOZw #TERN #8K #TernsPharmaceuticals #News
+ My List
VRPX Virpax Pharmaceuticals, Inc. - Common Stock 5.34% up -7.09% 12.43 + Pharmaceutical , Medicine

+ My List
VSPR Vesper Healthcare Acquisition Corp. - Class A Common Stock 0.00% 0 + Acquisitions/Investing, Medicine, Pharmaceutical , Healthcare

+ My List
UPC Universe Pharmaceuticals Inc - Ordinary Shares -8.53% -8.53% 0 + Country: China, Pharmaceutical , Medicine

+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.